1 |
Cieslik P, Kubeil M, Zarschler K, Ullrich M, Brandt F, Anger K, Wadepohl H, Kopka K, Bachmann M, Pietzsch J, Stephan H, Comba P. Toward Personalized Medicine: One Chelator for Imaging and Therapy with Lutetium-177 and Actinium-225. J Am Chem Soc 2022. [DOI: 10.1021/jacs.2c08438] [Reference Citation Analysis]
|
2 |
Shtykov SN. Coordination Compounds (Chelates) in Analytical Chemistry: Solutions, Sorbents, and Nanoplatforms. Russ J Coord Chem 2022;48:622-30. [DOI: 10.1134/s1070328422100062] [Reference Citation Analysis]
|
3 |
Hu A, Simms ME, Kertesz V, Wilson JJ, Thiele NA. Chelating Rare-Earth Metals (Ln3+) and 225Ac3+ with the Dual-Size-Selective Macrocyclic Ligand Py2-Macrodipa. Inorg Chem 2022. [PMID: 35914099 DOI: 10.1021/acs.inorgchem.2c01998] [Reference Citation Analysis]
|
4 |
Kadassery KJ, King AP, Fayn S, Baidoo KE, MacMillan SN, Escorcia FE, Wilson JJ. H2BZmacropa-NCS: A Bifunctional Chelator for Actinium-225 Targeted Alpha Therapy. Bioconjug Chem 2022;33:1222-31. [PMID: 35670495 DOI: 10.1021/acs.bioconjchem.2c00190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Tripier R, Tircsó G, Platas-iglesias C, Harriswangler C. Importance of ligand design in lanthanide azamacrocyclic complexes relevant to biomedical applications. Including Actinides 2022. [DOI: 10.1016/bs.hpcre.2022.05.001] [Reference Citation Analysis]
|